Perioperative and Long-Term Morbidity and Mortality After Above-Knee and Below-Knee Amputations in Diabetics and Nondiabetics
- 1 May 2005
- journal article
- Published by Wolters Kluwer Health in Anesthesia & Analgesia
- Vol. 100 (5) , 1241-1247
- https://doi.org/10.1213/01.ane.0000147705.94738.31
Abstract
We performed a retrospective review of a vascular surgery quality assurance database to evaluate the perioperative and long-term morbidity and mortality of above-knee amputations (AKA, n = 234) and below-knee amputations (BKA, n = 720) and to examine the effect of diabetes mellitus (DM) (181 of AKA and 606 of BKA patients). All patients in the database who had AKA or BKA from 1990 to May 2001 were included in the study. Perioperative 30-day cardiac morbidity and mortality and 3-yr and 10-yr mortality after AKA or BKA were assessed. The effect of DM on 30-day cardiac outcome was assessed by multivariate logistic regression and the effect on long-term survival was assessed by Cox regression analysis. The perioperative cardiac event rate (cardiac death or nonfatal myocardial infarction) was at least 6.8% after AKA and at most 3.6% after BKA. Median survival was significantly less after AKA (20 mo) than BKA (52 mo) (P < 0.001). DM was not a significant predictor of perioperative 30-day mortality (odds ratio, 0.76 [0.39-1.49]; P = 0.43) or 3-yr survival (Hazard ratio, 1.03 [0.86-1.24]; P = 0.72) but predicted 10-yr mortality (Hazard ratio, 1.34 [1.04-1.73]; P = 0.026). Significant predictors of the 30-day perioperative mortality were the site of amputation (odds ratio, 4.35 [2.56-7.14]; P < 0.001) and history of renal insufficiency (odds ratio, 2.15 [1.13-4.08]; P = 0.019). AKA should be triaged as a high-risk surgery while BKA is an intermediate-risk surgery. Long-term survival after AKA or BKA is poor, regardless of the presence of DM.Keywords
This publication has 21 references indexed in Scilit:
- Statins Are Associated With a Reduced Incidence of Perioperative Mortality in Patients Undergoing Major Noncardiac Vascular SurgeryCirculation, 2003
- ACC/AHA guideline update for perioperative cardiovascular evaluation for noncardiac surgery—executive summaryJournal of the American College of Cardiology, 2002
- Bisoprolol reduces cardiac death and myocardial infarction in high-risk patients as long as 2 years after successful major vascular surgeryEuropean Heart Journal, 2001
- Relationship of Unrecognised Myocardial Infarction, Diabetes Mellitus and Type of Surgery to Postoperative Cardiac Outcomes in Vascular SurgeryEuropean Journal of Vascular and Endovascular Surgery, 2001
- Perioperative- and Long-Term Mortality Rates After Major Vascular Surgery: The Relationship to Preoperative Testing in the Medicare PopulationAnesthesia & Analgesia, 1999
- Derivation and Prospective Validation of a Simple Index for Prediction of Cardiac Risk of Major Noncardiac SurgeryCirculation, 1999
- Association Between Age and Survival Following Major AmputationEuropean Journal of Vascular and Endovascular Surgery, 1999
- Effect of Atenolol on Mortality and Cardiovascular Morbidity after Noncardiac SurgeryNew England Journal of Medicine, 1996
- Major amputation in a defined population: Incidence, mortality and results of treatmentBritish Journal of Surgery, 1989
- Does Perioperative Myocardial Ischemia Lead to Postoperative Myocardial Infarction?Anesthesiology, 1985